Citation:Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, et al 2004

Citation

Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, et al. Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2004 Jun 2;96(11):879-82 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15173273.

Critical appraisals

• Assign a critical appraisal

Cited by

1. What is the evidence for the use of bisphosphonates in the prevention of skeletal related events?
2. What is the evidence for the use of bisphosphonates in the treatment of bone pain?